FDA plans ultra-fast review of three psychedelic drugs following Trump directive

FDA plans ultra-fast review of three psychedelic drugs following Trump directive.

National11 articles from 11 sources across the spectrum· Updated 158d ago

8 across the spectrum · tap a section to jump

How each side is putting it

Left

3 viewpoints

Scientific AmericanLean Left· 158d ago

RFK, Jr., puts psychedelics on fast track to FDA review and approval

The Boston GlobeLean Left· 158d ago· ran in 4 outlets

FDA plans ultra-fast review of three psychedelic drugs following Trump directive

Seattle TimesLean Left· 158d ago

FDA plans ultra-fast review of three psychedelic drugs after Trump directive

NBC NewsLean Left· 158d ago

FDA grants quick review for 3 psychedelic drug trials

4 viewpoints

NewsweekCenter· 158d ago

Trump order spurs FDA to speed reviews of psychedelic therapies

WMURCenter· 158d ago

FDA moves to fast-track review of psychedelic drugs for mental health

Ran by 4 outlets across the spectrum· The Columbian, WHEC Rochester

The ColumbianCenter· 158d ago

FDA plans ultra-fast review of three psychedelic drugs following Trump directive

WHEC RochesterCenter· 158d ago

FDA plans ultra-fast review of three psychedelic drugs following Trump directive

WHDH BostonLean Left· 158d ago

FDA plans ultra-fast review of three psychedelic drugs following Trump directive - Boston News, Weather, Sports

1 viewpoint

MyNorthwestLean Right· 158d ago· ran in 4 outlets

FDA plans ultra-fast review of three psychedelic drugs following Trump directive

FDA fast-tracks psychedelic drug research per Trump's request